Clinical trial
A Prospective, Observational Study of the Use of PuraPly™ Antimicrobial (PuraPly AM) in the Management of Wounds
NCT03070925 is registered in ClinicalTrials.gov with Organogenesis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Observational Study of the Use of PuraPly™ Antimicrobial (PuraPly AM) in the Management of Wounds
- Lead sponsor
- Organogenesis
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- May 31, 2017
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic ulcers, pressure ulcers, surgical wounds, trauma wounds, venous ulcers